Patent Assignment
Reel/Frame 063750/0642
Assignment of Assignor's Interest
Recorded: 2023-05-24
Pages: 11
Assignor
SALIX PHARMACEUTICALS, LTD.
Executed: 2018-11-14
Assignee
SALIX PHARMACEUTICALS, INC.
400 SOMERSET CORPORATE BLVD., BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Solid Dispersion Forms of Rifaximin
Application:
18/140,864 →
Publication:
US 2024/0100028
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 24, 2023
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 063750/0573 →
Intellectual Property Security Agreement
Aug 25, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 064719/0004 →
Second Lien Intellectual Property Security Agreement
Aug 25, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 064719/0013 →
Intellectual Property Security Agreement
Aug 25, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 064719/0022 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →